Cystathionine γ-Lyase Identified as a Key Regulator of Memory and Learning
January 1, 2026
Brand Name :
Trelegy Ellipta
Synonyms :
Class :
Corticosteroids, Beta2 Agonists
Dosage Forms & Strengths
Aerosol Powder Breath Activated
100 mcg/62.5 mcg/25 mcg-actuation- fluticasone furoate/umeclidinium/vilanterol
200 mcg/62.5 mcg/25 mcg -actuation- fluticasone furoate/umeclidinium/vilanterol
Initial dose:
1 inhalation of 100 mcg/62.5 mcg/25 mcg or 200 mcg/62.5 mcg/25 mcg (fluticasone/umeclidinium/vilanterol) orally once a day
Maximum dose: 1 inhalation of 200 mcg/62.5 mcg/25 mcg (fluticasone/umeclidinium/vilanterol) once a day
Safety and efficacy not established
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
Adverse drug reactions:
Frequency Defined
>10%
Nasopharyngitis
1-10%
Bronchitis
Respiratory tract infection
Back pain
Urinary tract infection
Influenza
Sinusitis
Headache
Upper respiratory tract infection
Pneumonia
Dysphonia
Oropharyngeal pain
Pregnancy warnings:
Pregnancy Category: N/A
Lactation: unknown if distributed into breast milk, avoid
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: Fluticasone furoate and vilanterol
Why do we use Fluticasone furoate and vilanterol?
fluticasone furoate, umeclidinium, and vilanterol is a Beta2 Agonists, Corticosteroids. It is used to treat COPD and severe Asthma.